When did Oric Pharmaceuticals, Inc. report Q4 2024 earnings?

Oric Pharmaceuticals, Inc. (ORIC) reported Q4 2024 earnings on February 18, 2025 before market open.

What were Oric Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?

Oric Pharmaceuticals, Inc. reported revenue of $533.0K and eps of $-0.51 for Q4 2024.

Did Oric Pharmaceuticals, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.52 by $0.01.

Where can I find Oric Pharmaceuticals, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-022273) directly on SEC EDGAR. The filing index links above go to sec.gov.

Oric Pharmaceuticals, Inc. ORIC Q4 2024 Annual earnings

Reported February 18, 2025 · Before market open

Revenue$533.0K

EPS-$0.51Beat by $0.01

EPS estimate-$0.52

Next report

Aug 11, 2026 (In 1 week)

EPS estimate-$0.36

Financials

Q4 2024

Income statement

See full

Operating income-$39.6M-25.9%

Net income-$36.3M-28.2%

EPS (diluted)-$0.51-2.0%

Balance sheet

See full

Cash & equivalents$59.4M+154%

Total debt$9.4M-8.4%

Total equity$243.1M+8.5%

Total assets$274.1M+8.8%

Cash flow

See full

Operating cash flow-$28.1M-15.6%

CapEx$219.0K+284%

Free cash flow-$28.3M-16.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$569.48M+7.7%

Enterprise value$519.43M+0.8%

Returns & leverage

See full

Return on equity-54.7%+14.8pp

Debt / equity0×0.0×

Current ratio10.6×+0.2×

Versus estimates

Revenue

Q4 2024$533.0K

Diluted EPS

Q1 2026-$0.34Miss by $0.03 Q4 2025-$0.30Beat by $0.04 Q3 2025-$0.33Beat by $0.08 Q2 2025-$0.47Miss by $0.01 Q1 2025-$0.42Beat by $0.09

Q4 2024-$0.51Beat by $0.01

Ask the moment Oric Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Oric Pharmaceuticals, Inc. report Q4 2024 earnings?: Oric Pharmaceuticals, Inc. (ORIC) reported Q4 2024 earnings on February 18, 2025 before market open.
What were Oric Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: Oric Pharmaceuticals, Inc. reported revenue of $533.0K and eps of $-0.51 for Q4 2024.
Did Oric Pharmaceuticals, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.52 by $0.01.
Where can I find Oric Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-022273) directly on SEC EDGAR. The filing index links above go to sec.gov.